Avid Bioservices Inc (USD)
CDMO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range4.52 | 4.83
52-Wk Range |
Last Close4.68
Mkt Cap (m)264.34
Dividend yield-
ISINUS05368M1062
Volume572,691
Exchange VenueNAS

Company Profile

Avid Bioservices Inc is engaged in development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.

Key Information
Price/Earning-
Price/Book5.61
Price/Sales4.10
P/CF31.22
Rev Growth (3 year avg)6.25
EPS Growth (3 year avg)-
Operating Margin % -10.49
Net Margin %-7.86
Return on Equity-16.36
Debt/Equity0.00

Documents

Prospectus
en 16/02/2018
Annual Report
en 30/04/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)222745585454
Operating Income (m)-36-50-56-28-19-6
Net Income (m)-35-50-56-28-22-4
Basic EPS-1.54-2.10-1.96-0.88-0.56-0.16
Avg. Diluted Shares Outstanding (m)232631374756
Balance Sheet
USD201420152016201720182019
Current Assets (m)868182896851
Non Current Assets (m)51727292827
Total Assets (m)91971091189678
Current Liabilities (m)223758633823
Total Liabilities (m)------
Total Equity (m)685950545653
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-28-36-40-40-27-12
Capital Expenditure (m)-1-9-9-2-3-2
Figures are quoted in USD unless stated otherwise
-
No change
$
4.68
Last Price